UNIK SUPPORT PROGRAM

Serial Number 98104648
Registration 7765117
700

Registration Progress

Application Filed
Jul 27, 2023
Under Examination
Approved for Publication
Mar 4, 2025
Published for Opposition
Mar 4, 2025
Registered
Apr 22, 2025

Trademark Image

UNIK SUPPORT PROGRAM

Basic Information

Serial Number
98104648
Registration Number
7765117
Filing Date
July 27, 2023
Registration Date
April 22, 2025
Published for Opposition
March 4, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 22, 2025
Registration
Registered
Classes
035

Rights Holder

Médunik Canada inc.

99
Address
950 Boul Michèle-Bohec
Blainville, QUEBEC J7C5E2
CA

Ownership History

Médunik Canada inc.

Original Applicant
99
Blainville, QUEBEC CA

Médunik Canada inc.

Owner at Publication
99
Blainville, QUEBEC CA

Médunik Canada inc.

Original Registrant
99
Blainville, QUEBEC CA

Legal Representation

Attorney
Charles G. Zug

USPTO Deadlines

Next Deadline
1947 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250422)
Due Date
April 22, 2031
Grace Period Ends
October 22, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Apr 22, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 22, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 4, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 4, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 26, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 6, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 4, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 4, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 4, 2025 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Nov 4, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Nov 4, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Nov 4, 2024 CNFR R FINAL REFUSAL WRITTEN Loading...
Oct 2, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 2, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 2, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 1, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jul 1, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Apr 5, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 5, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 5, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 28, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 5, 2023 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Aug 27, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 31, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Organization and management of a membership program which entitles participants access to orphan drugs through a network of participating retailers; providing information on pharmaceuticals and pharmaceutical benefit programs, namely, sample card programs, patient financial assistance programs, patient benefit programs, patient choice programs and compassionate programs; patient relationship management services in the nature of arranging and conducting of patient meetings; preparing business reports; compilation of statistics; operation and management of telephone call centers for others; patient relationship management services; consulting services in the field of patient relationship management for healthcare providers; business administration of a patient support program for facilitating access to pharmaceutical products from pharmaceutical manufacturers; business administration of a patient support program for facilitating the reimbursement of pharmaceutical products; business administration of a patient support program for facilitating the distribution of pharmaceutical products from pharmaceutical manufacturers; assisting patients in enrolling in pharmaceutical reimbursement programs of others; telephone answering services; processing telephone inquiries regarding advertised goods and services; promoting awareness to medical specialists in the field of pharmaceutical and patient care; managed care services, namely, electronic processing of health care information related to the transmission of data from and to electronic medical records (EMR), patient lab results, medical documents and information related to patient management and medication management
First Use Anywhere: Dec 30, 2022
First Use in Commerce: Dec 30, 2022

Classification

International Classes
035

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"SUPPORT PROGRAM"